The IFN‐γ level in the spleen lymphocyte supernatant of the Lewis lung cancer model mice immunized in the control group (784.54 pg/ml) was lower than the low‐dose group (832.67 pg/ml) (p > 0.05). The gene discussed is IFNG; the disease is lung carcinoma.